OctoPlus N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 01 feb 2012 - 22:19

Statutaire naam OctoPlus N.V.

Titel OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S

Bericht OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), announces today that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company. The undisclosed contract value will make a material contribution to OctoPlus’ 2012 revenues. Further details on the compound and activities are not disclosed.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201202010000000018_OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals AS.pdf (opens in a new window)

201202010000000018_OctoPlus verkrijgt ontwikkelings- en productiecontract van….pdf (opens in a new window)

Datum laatste update: 27 juli 2024